IRIS Accounts Production v24.2.0.383 11149212 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111492122023-01-31111492122024-01-31111492122023-02-012024-01-31111492122022-01-31111492122022-02-012023-01-31111492122023-01-3111149212ns15:EnglandWales2023-02-012024-01-3111149212ns14:PoundSterling2023-02-012024-01-3111149212ns10:Director12023-02-012024-01-3111149212ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3111149212ns10:SmallEntities2023-02-012024-01-3111149212ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3111149212ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3111149212ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3111149212ns10:AbridgedAccounts2023-02-012024-01-311114921212023-02-012024-01-3111149212ns10:OrdinaryShareClass12023-02-012024-01-3111149212ns10:Director22023-02-012024-01-3111149212ns10:Director32023-02-012024-01-3111149212ns10:RegisteredOffice2023-02-012024-01-3111149212ns5:CurrentFinancialInstruments2024-01-3111149212ns5:CurrentFinancialInstruments2023-01-3111149212ns5:ShareCapital2024-01-3111149212ns5:ShareCapital2023-01-3111149212ns5:RetainedEarningsAccumulatedLosses2024-01-3111149212ns5:RetainedEarningsAccumulatedLosses2023-01-3111149212ns5:IntangibleAssetsOtherThanGoodwill2023-02-012024-01-3111149212ns5:PlantMachinery2023-02-012024-01-3111149212ns5:FurnitureFittings2023-02-012024-01-3111149212ns5:MotorVehicles2023-02-012024-01-3111149212ns5:ComputerEquipment2023-02-012024-01-3111149212ns10:OrdinaryShareClass12024-01-3111149212ns5:RetainedEarningsAccumulatedLosses2023-01-3111149212ns5:RetainedEarningsAccumulatedLosses2023-02-012024-01-31
REGISTERED NUMBER: 11149212 (England and Wales)












MEDINOX (LONDON) LIMITED

REPORT OF THE DIRECTORS AND

ABRIDGED UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2024






MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024










Page

Company Information 1

Report of the Directors 2

Abridged Balance Sheet 3

Notes to the Financial Statements 5


MEDINOX (LONDON) LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2024







DIRECTORS: Mr D S Brown
Mr G J Matheson
Mr K C Venn





REGISTERED OFFICE: Sterling House
Fulbourne Road
Walthamstow
London
E17 4EE





REGISTERED NUMBER: 11149212 (England and Wales)





ACCOUNTANTS: Christiansons Ltd
Chartered Certified Accountants
Sterling House
Fulbourne Road
Walthamstow
London
E17 4EE

MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 31 JANUARY 2024


The directors present their report with the financial statements of the company for the year ended 31 January 2024.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of the trading of medical goods.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2023 to the date of this report.

Mr D S Brown
Mr G J Matheson
Mr K C Venn

POLITICAL DONATIONS AND EXPENDITURE
There were no political donations during the period (2023: NIL). Charitable donations for the year were £50 (2023: £1,296).

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Mr G J Matheson - Director


18 August 2024

MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

ABRIDGED BALANCE SHEET
31 JANUARY 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 69,807 90,798
Tangible assets 5 4,888 7,093
74,695 97,891

CURRENT ASSETS
Stocks 342,063 290,819
Debtors 376,025 243,268
Cash at bank and in hand 18,449 23,705
736,537 557,792
CREDITORS
Amounts falling due within one year 1,910,482 1,835,984
NET CURRENT LIABILITIES (1,173,945 ) (1,278,192 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(1,099,250

)

(1,180,301

)

CAPITAL AND RESERVES
Called up share capital 6 123 123
Retained earnings 7 (1,099,373 ) (1,180,424 )
SHAREHOLDERS' FUNDS (1,099,250 ) (1,180,301 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

ABRIDGED BALANCE SHEET - continued
31 JANUARY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 August 2024 and were signed on its behalf by:





Mr G J Matheson - Director


MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2024


1. STATUTORY INFORMATION

Medinox (London) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts derived from the sale of goods to customers during the year, and is recognised at the date the risks and rewards of ownership of goods were transferred to the customer. This is stated after trade discounts, other sales taxes and net of VAT.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Registered trademarks are being amortised evenly over their estimated useful life of between 4 and 10 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Fixtures and fittings - 25% on cost
Motor vehicles - 25% on cost
Computer equipment - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The company has accumulated losses and is dependent on continued financial support by its
directors. The directors have considered the next twelve months after the date of approval of these financial
statements and believe the company is a going concern. The directors have undertaken to support the company for the next twelve months from the date of approval of these financial statements.

MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023
and 31 January 2024 907,344
AMORTISATION
At 1 February 2023 816,546
Amortisation for year 20,991
At 31 January 2024 837,537
NET BOOK VALUE

At 31 January 2024 69,807
At 31 January 2023 90,798

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023 26,123
Additions 1,687
At 31 January 2024 27,810
DEPRECIATION
At 1 February 2023 19,030
Charge for year 3,892
At 31 January 2024 22,922
NET BOOK VALUE
At 31 January 2024 4,888
At 31 January 2023 7,093

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
12,346 Ordinary £0.01 123 123

MEDINOX (LONDON) LIMITED (REGISTERED NUMBER: 11149212)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2024


7. RESERVES
Retained
earnings
£   

At 1 February 2023 (1,180,424 )
Profit for the year 81,051
At 31 January 2024 (1,099,373 )

8. ULTIMATE CONTROLLING PARTY

There is no overall control of the company by any one person.